For instance, sequence remodeling and extension led to the discovery of exenatide (Byetta), a 39-amino acid synthetic peptide with 50% sequence identity to GLP-1, derived from exendin-4, a peptide found in the venom of the Gila monster Heloderma suspectum (Van Baelen et al., 2022)
Despite most individuals being eligible for semaglutide due to weight management, which is an indication not always covered by payers, more than 39 million adults may qualify for indications other than weight management alone
The question is no longer whether glutathione can be raised
For now, the competitive tension remains theoretical
While continuous-flow peptide synthesis is being developed to address some of these limitations, it remains at an early stage of industrial implementation